Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Viridian Therapeutics, Inc.\DE (VRDN)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
22 Jan 2024
Fairmount Funds Management LLC
Director, 10% Owner, See Remarks
Viridian Therapeutics, Inc.\DE
(VRDN)
1,839,954
+34%
476,190
$21.00
$9,999,990.00
SELL
15 Jun 2023
Meisner Lara
Chief Legal Officer, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
29,971
-7%
2,296
$28.02
$64,342.83
SELL
2 Jun 2023
Meisner Lara
Chief Legal Officer, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
29,971
-20%
7,500
$24.82
$186,136.25
BUY
12 Apr 2023
Myers Scott Dunseth
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
259,500
+1%
4,000
$25.37
$101,478.80
SELL
2 Feb 2023
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
430,905
-10%
50,000
$36.80
$1,840,000.00
SELL
2 Feb 2023
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
480,905
-9%
50,000
$36.80
$1,840,000.00
SELL
23 Jan 2023
Meisner Lara
General Counsel and Secretary, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
6,843
$35.66
$244,021.38
SELL
13 Jan 2023
Katz Barrett
Chief Medical Officer, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
29,000
$37.18
$1,078,260.60
SELL
9 Jan 2023
Katz Barrett
Chief Medical Officer, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
60,000
$34.82
$2,089,472.00
SELL
20 Dec 2022
Meisner Lara
General Counsel and Secretary, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
16,926
$29.15
$493,397.94
SELL
15 Dec 2022
Meisner Lara
General Counsel and Secretary, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
1,597
$28.37
$45,310.68
SELL
12 Dec 2022
Meisner Lara
General Counsel and Secretary, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
16,256
$28.12
$457,076.72
SELL
15 Nov 2022
Meisner Lara
General Counsel and Secretary, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
0
-100%
8,125
$22.05
$179,156.25
BUY
17 Aug 2022
Fairmount Funds Management LLC
Director, 10% Owner, See Remarks
Viridian Therapeutics, Inc.\DE
(VRDN)
1,363,764
+45%
425,531
$23.50
$9,999,978.00
SELL
1 Jun 2022
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
480,905
-5%
30,000
$12.20
$366,000.00
SELL
2 May 2022
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
510,905
-5%
30,000
$13.04
$391,200.00
SELL
1 Apr 2022
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
540,905
-5%
30,000
$18.92
$567,636.00
SELL
1 Mar 2022
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
570,905
-4%
30,000
$17.65
$529,491.25
SELL
1 Feb 2022
Violin Jonathan
Chief Executive Officer, Director, Officer
Viridian Therapeutics, Inc.\DE
(VRDN)
600,905
-4%
30,000
$19.09
$572,818.25
BUY
23 Sep 2021
Frazier Life Sciences Public Fund, L.P.
10% Owner
Viridian Therapeutics, Inc.\DE
(VRDN)
1,505,200
+15%
200,000
$11.00
$2,200,000.00
BUY
21 Sep 2021
Fairmount Funds Management LLC
Director, 10% Owner
Viridian Therapeutics, Inc.\DE
(VRDN)
938,233
+3109%
909,000
$11.00
$9,999,000.00
BUY
9 Nov 2020
Logos Global Master Fund LP
10% Owner
MIRAGEN THERAPEUTICS, INC.
(MGEN)
550,000
+6%
31,777.8
$71.45
$2,270,484.00
BUY
11 Oct 2018
Hughes Thomas E.
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
12,827
+5%
666.667
$71.55
$47,697.00
BUY
13 Feb 2018
Levy Adam Scott
Chief Business Officer, Officer
MIRAGEN THERAPEUTICS, INC.
(MGEN)
10,540
+6%
606
$82.50
$49,995.00
BUY
13 Feb 2018
Booth Bruce
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
1,351,090
+2%
36,363.6
$82.50
$2,999,997.00
SELL
20 Dec 2017
Hughes Thomas E.
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
2,827
-22%
800
$120.00
$96,000.00
BUY
22 Jun 2017
Levy Adam Scott
Chief Business Officer, Officer
MIRAGEN THERAPEUTICS, INC.
(MGEN)
200
+7%
13.333
$113.25
$1,510.00
SELL
9 Mar 2017
LEFKOFF KYLE
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
463,473
-0%
386.667
$215.15
$83,190.44
SELL
6 Mar 2017
LEFKOFF KYLE
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
469,273
-0%
1,000
$230.98
$230,977.44
SELL
24 Feb 2017
LEFKOFF KYLE
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
484,273
-0%
683.867
$208.40
$142,518.80
SELL
22 Feb 2017
LEFKOFF KYLE
Director
MIRAGEN THERAPEUTICS, INC.
(MGEN)
494,531
-0%
393.467
$212.09
$83,451.71
Home